Core Viewpoint - The company has entered into a strategic cooperation framework agreement with Medtronic to promote real-time navigation tracking endoscopic technology for spinal applications in China [1] Group 1: Strategic Cooperation - The agreement involves the development of a leading domestic and internationally advanced integrated solution for navigation spinal endoscopy based on clinical needs [1] - Resources will be allocated to organize academic exchange activities domestically and internationally to promote clinical academic exchange and technological advancement of the real-time navigation tracking endoscopic technology in China [1] - Both parties will provide navigation spinal endoscopy prototypes for clinical demonstrations, training, and marketing activities to support the testing and evaluation of the real-time navigation tracking endoscopic technology [1]

Core Viewpoint - The strategic cooperation framework agreement between Jinhai Medical Technology and Medtronic aims to promote the clinical application of real-time navigation tracking spinal endoscopy technology in China [1] Group 1: Strategic Cooperation Details - The agreement involves the development of a leading domestic and internationally advanced integrated solution for navigation spinal endoscopy based on clinical needs [1] - Resources will be allocated to organize domestic and international academic exchange activities to enhance clinical academic communication and technological advancement of the real-time navigation tracking spinal endoscopy technology in China [1] - Both parties will provide navigation spinal endoscopy prototypes for clinical demonstrations, training, and marketing activities to support the testing and evaluation of the technology [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任 何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Jinhai Medical Technology Limited 今海醫療科技股份有限公司 （股份代號：2225） （於開曼群島註冊成立的成員有限責任公司） 自願公告 戰略合作框架協議 茲提述今海醫療科技股份有限公司（「本公司」，連同其附屬公司統稱「本集團」） 日期為二零二五年十月十五日之自願公告（「十月自願公告」）。本公告乃由本公司 自願作出，旨在向其股東及潛在投資者提供有關本集團業務近期發展的最新情況。 除本公告另有界定者外，本公告所用詞彙與十月自願公告所界定者具有相同涵義。 有關美敦力常州的資料 美敦力常州為一間於中國成立之有限責任公司，主要從事醫療器械的製造及銷售。 美敦力常州為美敦力之間接全資附屬公司。 據董事經作出一切合理查詢後所知、所悉及所信，美敦力常州及美敦力為獨立於 本公司及其關連人士（定義見聯交所證券上市規則）的獨立第三方。 本公司董事（「董事」）會（「董事會」）欣然宣佈，於二零二 ...

Core Viewpoint - The stock of Jiuhai Medical Technology (02225.HK) experienced a significant increase, rising over 15% during trading, and is currently up 5.04% at HKD 1.25, with a trading volume of HKD 12.1974 million [1] Group 1 - Jiuhai Medical Technology's stock price increased by over 15% during the trading session [1] - As of the latest update, the stock is up 5.04%, trading at HKD 1.25 [1] - The total trading volume reached HKD 12.1974 million [1]

Core Viewpoint - Jin Hai Medical Technology (02225) has seen a significant stock price increase, attributed to its collaboration with Medtronic China to launch innovative navigation technology for spinal endoscopy during the 8th China International Import Expo [1] Company Summary - Jin Hai Medical Technology's stock rose over 15% during trading, currently up 5.04% at HKD 1.25, with a trading volume of HKD 12.1974 million [1] - The company announced a partnership with Medtronic China to unveil new navigation technology aimed at enhancing precision and intelligence in spinal surgeries [1] Industry Summary - The 8th China International Import Expo will take place from November 5 to 10 in Shanghai, providing a platform for showcasing innovative medical technologies [1] - Medtronic's core business includes the development, manufacturing, distribution, and sales of medical therapies and services across cardiovascular, neuroscience, surgical, and diabetes sectors [1] - Medtronic has participated in the Import Expo for seven consecutive years since its inception in 2018, leveraging the event's influence to accelerate the application of its latest medical innovations [1]

Core Viewpoint - Jin Hai Medical Technology (02225) experienced a significant stock price increase, rising over 15% during trading and currently up 5.04% at HKD 1.25, with a trading volume of HKD 12.1974 million [1] Group 1: Company Developments - Jin Hai Medical announced a collaboration with Medtronic China to unveil a new navigational spinal endoscopy innovation during the 8th China International Import Expo, scheduled from November 5 to 10 in Shanghai [1] - The new technology is expected to enhance precision and intelligence in spinal surgeries, reducing the learning curve for clinicians in spinal endoscopy techniques and promoting more efficient and widespread clinical applications in the future [1] Group 2: Industry Context - Medtronic's primary business includes the development, manufacturing, distribution, and sales of medical therapies and services in cardiovascular disease, neuroscience, surgical technologies, and diabetes [1] - Medtronic has established production bases in Shanghai, Changzhou, and Chengdu, and has participated in the China International Import Expo for seven consecutive years since its inception in 2018, leveraging the event's influence to showcase and accelerate the application of its latest innovative medical technologies and products [1]

Core Viewpoint - The stock of Jianghai Medical Technology (02225.HK) experienced a significant increase, rising over 6% in the late trading session, indicating positive market sentiment towards the company [1] Company Summary - Jianghai Medical Technology's stock price rose by 6.19%, reaching 1.2 HKD per share [1] - The trading volume for the stock was reported at 29.22 million HKD, reflecting active investor interest [1]

Core Viewpoint - Jinhai Medical Technology (02225) experienced a significant stock increase of over 6%, closing at 1.2 HKD with a trading volume of 29.22 million HKD, driven by the announcement of a new innovative technology in spinal surgery during the China International Import Expo [1] Company Summary - Jinhai Medical is set to jointly launch a new navigation-based endoscopic technology for spinal surgery in collaboration with Medtronic China during the eighth China International Import Expo [1] - This innovative technology aims to enhance precision and intelligence in spinal surgeries, potentially shortening the learning curve for clinicians in endoscopic techniques [1] - The expected outcome is a more efficient and widespread clinical application of spinal surgery techniques, marking a significant advancement in the field [1] Industry Summary - The announcement aligns with ongoing trends in the medical technology industry towards increased precision and efficiency in surgical procedures [1] - The collaboration with a major player like Medtronic China highlights the importance of partnerships in driving innovation within the healthcare sector [1]

Core Viewpoint - The stock of Jin Hai Medical Technology (02225) rose over 6% following the announcement of a collaboration with Medtronic China to launch a new navigation-based spinal endoscopy technology during the 8th China International Import Expo [1] Group 1: Company Performance - Jin Hai Medical's stock increased by 6.19%, reaching HKD 1.2, with a trading volume of HKD 29.22 million [1] Group 2: Industry Developments - The 8th China International Import Expo and Hongqiao International Economic Forum commenced in Shanghai on November 5 [1] - During the expo, Jin Hai Medical will jointly unveil innovative navigation-based spinal endoscopy technology with Medtronic China, aimed at enhancing precision and intelligence in spinal surgeries [1] - The new technology is expected to shorten the learning curve for clinicians in spinal endoscopy techniques and promote more efficient and widespread clinical applications in the future [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 今海醫療科技股份有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02225 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 8,000,000,000 | HKD | | 0.0025 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 8,000,000,000 | HKD | | 0.0025 | HKD | | 20,000,000 | 本月 ...